Miami, FL — February 2026 — SPINA TEAM, a rising distributor in advanced spinal implant technologies, has begun distributing the UniSpace® Stand-Alone C Cage — a next-generation cervical interbody fusion device designed to improve surgical outcomes in anterior cervical discectomy and fusion (ACDF) procedures.

The UniSpace® Stand-Alone C Cage, manufactured by CG MedTech Corporation, is a cutting-edge anterior cervical interbody fusion implant engineered to provide stability, promote fusion, and streamline surgical workflow for patients with cervical disc disease. This launch represents a strategic expansion of SPINA TEAM’s portfolio into high-performance spinal implant solutions tailored for modern spine surgery.

What Makes UniSpace® Stand-Alone C Cage Special?

The UniSpace® device incorporates several advanced design features that distinguish it in the stand-alone cervical cage category:

• Biomimetic lattice structure — The implant’s 3D-printed porous titanium body features dual porosity zones and a large graft window, encouraging both bone ongrowth and ingrowth. This supports fusion biology and helps reduce subsidence (implant settling).

• Integrated, self-locking screws — The device uses built-in fixation screws with an automatic locking mechanism that provides secure stabilization without supplemental anterior plating. Visual confirmation features help ensure proper screw placement and locking.

• Customizable fit — Variable screw angles and a range of implant sizes make it adaptable to patient anatomy, improving surgical versatility.

These innovations reflect the broader trend in cervical fusion toward stand-alone devices that simplify instrumentation, maintain disc height, and reduce soft-tissue disruption compared with traditional plate-and-cage constructs.

Indications and Surgical Use

The UniSpace® Stand-Alone C Cage is indicated for skeletally mature patients with symptomatic cervical disc disease ranging from C2–C3 to C7–T1 levels. It is implanted via an anterior surgical approach and may be used with autogenous or allogenic bone graft material to facilitate fusion. In cases with greater lordotic angles (≥20°), the device can be complemented with an FDA-cleared supplemental fixation system.

Clinical Significance

Stand-alone cervical cages like UniSpace® are increasingly adopted in ACDF due to several advantages over traditional cage-plate constructs — such as reduced operative time, less soft-tissue dissection, and potentially lower rates of postoperative dysphagia. These devices aim to deliver robust structural support while staying low-profile, particularly valuable in single-level cervical procedures.

By expanding into distribution of the UniSpace® Stand-Alone C Cage, SPINA TEAM is positioning itself to support spine surgeons and healthcare facilities with access to technologically advanced implants that align with modern surgical trends and patient-centric care goals.